Product NDC: | 58809-907 |
Proprietary Name: | VANACOF |
Non Proprietary Name: | Chlophedianol Hydrochloride, Guaifenesin, and Pseudoephedrine Hydrochloride |
Active Ingredient(s): | 12.5; 100; 30 mg/5mL; mg/5mL; mg/5mL & nbsp; Chlophedianol Hydrochloride, Guaifenesin, and Pseudoephedrine Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58809-907 |
Labeler Name: | GM Pharmaceuticals |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20080423 |
Package NDC: | 58809-907-02 |
Package Description: | 12 BOTTLE in 1 TRAY (58809-907-02) > 15 mL in 1 BOTTLE |
NDC Code | 58809-907-02 |
Proprietary Name | VANACOF |
Package Description | 12 BOTTLE in 1 TRAY (58809-907-02) > 15 mL in 1 BOTTLE |
Product NDC | 58809-907 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Chlophedianol Hydrochloride, Guaifenesin, and Pseudoephedrine Hydrochloride |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20080423 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | GM Pharmaceuticals |
Substance Name | CHLOPHEDIANOL HYDROCHLORIDE; GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 12.5; 100; 30 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |